Abstract:IntroductionThe proportion of people living with HIV (PLH) in care and on antiretroviral therapy (ART) in Russia is lower than in Sub-Saharan Africa [1]. This is undoubtedly due to a variety of systems and structural issues related to poor treatment access, linkage and care delivery models. However, little research has explored the reasons that PLH are not in care from their own perspectives. This information can help to guide the development of approaches for improving HIV care engagement in the country.Mater… Show more
“…Active outreach that encourages engagement in care ought to be enacted to connect these individuals to the HIV and drug treatment services they need to maximize their health and, potentially, protect that of their drug-using and sexual partners. Previous qualitative research with people with HIV in St. Petersburg has underscored the importance of perceived quality of medical staff/services and trust in one’s doctor as determinants of health service utilization [12]. Strengthening protocols to protect patients’ private health information within clinical care settings, communicating the value placed on such confidentiality to patients, and supporting patient–provider relationship-building over time through continuity of care may help to reduce the fears of confidentiality being breached and distrust of doctors commonly expressed as barriers to care by socially marginalized groups in Russia [12, 13].…”
Section: Discussionmentioning
confidence: 99%
“…Attitudinal studies in Russia have highlighted pervasive stigma directed toward both people with HIV [21–23] and people who inject drugs [24, 25] as well as the potential deterrent effect of HIV and drug stigmas on service utilization [12, 13, 24–26]. Fear of confidentiality being breached and anticipated harm to personal and professional relationships are among the most common barriers to care reported by people with HIV in St. Petersburg [12].…”
Section: Introductionmentioning
confidence: 99%
“…Fear of confidentiality being breached and anticipated harm to personal and professional relationships are among the most common barriers to care reported by people with HIV in St. Petersburg [12]. People who use drugs face similar social penalties and barriers to care, which are structurally reinforced: Access to drug treatment in Russia typically requires formal registration as a drug user and monitoring for 5 years following treatment, during which time quality of life can be significantly compromised by restrictions on employment, licensure to drive, and military service.…”
Marked overlap between the HIV and injection drug use epidemics in St. Petersburg, Russia, puts many people in need of health services at risk for stigmatization based on both characteristics simultaneously. The current study examined the independent and interactive effects of internalized HIV and drug stigmas on health status and health service utilization among 383 people with HIV who inject drugs in St. Petersburg. Participants self-reported internalized HIV stigma, internalized drug stigma, health status (subjective rating and symptom count), health service utilization (HIV care and drug treatment), sociodemographic characteristics, and health/behavioral history. For both forms of internalized stigma, greater stigma was correlated with poorer health and lower likelihood of service utilization. HIV and drug stigmas interacted to predict symptom count, HIV care, and drug treatment such that individuals internalizing high levels of both stigmas were at elevated risk for experiencing poor health and less likely to access health services.
“…Active outreach that encourages engagement in care ought to be enacted to connect these individuals to the HIV and drug treatment services they need to maximize their health and, potentially, protect that of their drug-using and sexual partners. Previous qualitative research with people with HIV in St. Petersburg has underscored the importance of perceived quality of medical staff/services and trust in one’s doctor as determinants of health service utilization [12]. Strengthening protocols to protect patients’ private health information within clinical care settings, communicating the value placed on such confidentiality to patients, and supporting patient–provider relationship-building over time through continuity of care may help to reduce the fears of confidentiality being breached and distrust of doctors commonly expressed as barriers to care by socially marginalized groups in Russia [12, 13].…”
Section: Discussionmentioning
confidence: 99%
“…Attitudinal studies in Russia have highlighted pervasive stigma directed toward both people with HIV [21–23] and people who inject drugs [24, 25] as well as the potential deterrent effect of HIV and drug stigmas on service utilization [12, 13, 24–26]. Fear of confidentiality being breached and anticipated harm to personal and professional relationships are among the most common barriers to care reported by people with HIV in St. Petersburg [12].…”
Section: Introductionmentioning
confidence: 99%
“…Fear of confidentiality being breached and anticipated harm to personal and professional relationships are among the most common barriers to care reported by people with HIV in St. Petersburg [12]. People who use drugs face similar social penalties and barriers to care, which are structurally reinforced: Access to drug treatment in Russia typically requires formal registration as a drug user and monitoring for 5 years following treatment, during which time quality of life can be significantly compromised by restrictions on employment, licensure to drive, and military service.…”
Marked overlap between the HIV and injection drug use epidemics in St. Petersburg, Russia, puts many people in need of health services at risk for stigmatization based on both characteristics simultaneously. The current study examined the independent and interactive effects of internalized HIV and drug stigmas on health status and health service utilization among 383 people with HIV who inject drugs in St. Petersburg. Participants self-reported internalized HIV stigma, internalized drug stigma, health status (subjective rating and symptom count), health service utilization (HIV care and drug treatment), sociodemographic characteristics, and health/behavioral history. For both forms of internalized stigma, greater stigma was correlated with poorer health and lower likelihood of service utilization. HIV and drug stigmas interacted to predict symptom count, HIV care, and drug treatment such that individuals internalizing high levels of both stigmas were at elevated risk for experiencing poor health and less likely to access health services.
“…The experience of stigma may also be detrimental to the physical health of PLWH and interfere with their ability to manage the disease, including delayed or avoidance of HIV testing [22][23][24][25] and poor engagement in care [26,27]. A recent meta-analysis concluded that HIV-related stigma is associated with several physical health indicators, including AIDS-related symptoms, clinical stage of the disease, and self-reported physical health [17].…”
This paper provides a review of the quantitative literature on HIV-related stigma and medication adherence, including: (1) synthesis of the empirical evidence linking stigma to adherence, (2) examination of proposed causal mechanisms of the stigma and adherence relationship, and (3) methodological critique and guidance for future research. We reviewed 38 studies reporting either cross-sectional or prospective analyses of the association of HIV-related stigma to medication adherence since the introduction of antiretroviral therapies (ART). Although there is substantial empirical evidence linking stigma to adherence difficulties, few studies provided data on psychosocial mechanisms that may account for this relationship. Proposed mechanisms include: (a) enhanced vulnerability to mental health difficulties, (b) reduction in self-efficacy, and (c) concerns about inadvertent disclosure of HIV status. Future research should strive to assess the multiple domains of stigma, use standardized measures of adherence, and include prospective analyses to test mediating variables.
“…The results of this study suggest that in the event that stigma reduces and there is an increase Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 12 June 2017in social engagement, the people will cope favourably with their conditions as earlier highlighted (Kelly et al, 2014). …”
Background: Human Immnodeficiency virus (HIV) continues to take a heavy toll on the lives of many people with worst impact on health and wellbeing for the affected individuals in fragile states. The HIV situation in Somalia is not clearly known and experiences of the people living with HIV in this war-torn region unexpressed. This pilot qualitative study sought to explore the experiences of people living with diagnosed HIV in Mogadishu and their resilience in access to care and social support. Method: Face-to-face in-depth interviews were conducted in Somali in May 2013 among patients who were receiving Antiretroviral therapy (ART) from the HIV clinic in Mogadishu. Participants were recruited through drug dispensers at the HIV clinic in Benader Hospital. These were tape recorded, transcribed and translated for content analysis. Results: Three women and four men who were living with HIV shared the following narratives. Their perception was that they had either got HIV from their spouces or through health care contamination. They were very knowledgable about the realities of HIV, how the medication works, nutritional requirements and drug adherence. They were always willing to go an extra mile to secure a good life for themselves. However the external HIV stigma impacted their access to care. They faced challenges in their homes and at work which compelled them to seek support from non-governmental organisations (NGOs) or close family members. This stigma often affected their disclosure to the wider community due to the uncertainity of the repercussions, leading to a life of extreme loneliness and financial difficulties. The participants’ coping mechansms included living together and starting their own NGO for support with very strong optimism about their prognosis. Conclusions: The people living with diagnosed HIV in Mogadishu are highly knowledgeable about HIV transmission, the realities of living with diagnosed HIV infection and efficacy of HIV treatment. Our small sample suggests adequate access to ART through NGOs. However, widespread HIV stigma limits HIV status disclosure to the families and communities which creates a risk of self isolation and ill health. But affected individuals have developed resilient mechanisms of managing the risks. They strive to remain employed for economic security, adhere to HIV treatment, engage in support groups and maintain utmost optimism about their prognosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.